CoChat

A prospective study of the prevalence of clear‐cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia

O'Driscoll, J. B., Mamtora, H., Higginson, J., Pollock, A., Kane, J., Anderson, D. C. · 1994 · Clinical Endocrinology
Cited by 152

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Summary: OBJECTIVE To determine the frequency of polycystic ovaries (PCO) on ultrasound and the incidence of clear‐cut endocrine disorders leading to virilization in patients complaining of hirsutism or androgenic alopecia. The major purpose was to determine a coherent policy for the routine biochemical assessment of such women. DESIGN A prospective study of women attending a joint skin/endocrine clinic complaining of these problems. PATIENTS Three hundred and fifty consecutive women with hirsutism and/or androgenic alopecia were assessed. MEASUREMENTS Baseline endocrine screens were conducted on two occasions and included measurement of serum testosterone, androstenedione, dehydroepiandrosterone sulphate, sex hormone binding globulin, LH, FSH, 17‐hydroxyprogesterone and PRL. The ovarles were visualized by high‐resolution pelvic ultrasound scanning. RESULTS Eight women were identified with relevant endocrine disorders; of these, one was acromegalic and one had a microprolactinoma—In both cases the association may have been fortuitous. Three had clear‐cut 21‐hydroxylase deficiency, one a rare hepatic enzyme deficiency (11‐reductase), one a virilizing adrenal carclnoma and one a Leydig cell tumour. The latter six cases all had persistently elevated levels of serum testosterone (>5nmol/l). In ail, 13 women had baseline testosterone levels in excess of 5nmol/l. Polycystic ovaries were present in 81 % of the cases who had erratic cycles and 52% of those with regular cycles; PCO were present In two of the women with 21‐hydroxylase deficiency and In the woman with 11‐oxoreductase deficiency. The Leydig cell tumour (1.2 cm diameter) was not detected on ultrasound or CT scan. CONCLUSIONS For the exclusion of enzyme deficiencies and virllizing tumours clinical assessment and a single serum testosterone measurement will suffice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.1994.tb02535.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 152

Metadata

Authors
O'Driscoll, J. B., Mamtora, H., Higginson, J., Pollock, A., Kane, J., & Anderson, D. C.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
1994-08
Volume
41
Issue
2
Pages
231-236
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2016610386
Cited by
152
References
1
FWCI
2.49
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A prospective study of the prevalence of clear‐cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia. https://app.cochat.ai/papers/10.1111/j.1365-2265.1994.tb02535.x
The paper
O'Driscoll, J. B., Mamtora, H., Higginson, J., Pollock, A., Kane, J., & Anderson, D. C. (1994). A prospective study of the prevalence of clear‐cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.1994.tb02535.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.